Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 500 of 1,261
  1. US 10285937

    Method and apparatus for treating ear infections

    Try This First, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  2. US 10285913

    Dental polymerizable composition, dental temporary cement, dental filling material, denture liner, and dental tissue conditioner

    KURARAY NORITAKE DENTAL INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  3. US 10285388

    Non-human animals having a disruption in a C9ORF72 locus

    REGENERON PHARMACEUTICALS, INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  4. US 10285935

    Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology

    United States Department of Veteran Affairs · Granted May 14, 2019 · Expires May 9, 2039

    granted
  5. US 10279010

    Methods and compositions for modulating myofibroblast activities

    The Regents of the University of California · Granted May 7, 2019 · Expires May 2, 2039

    granted
  6. US 10280414

    Stabilized α-galactosidase and uses thereof

    Protalix Ltd. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  7. US 10278977

    Methods for treating hypersomnolence

    Umecrine Cognition AB · Granted May 7, 2019 · Expires May 2, 2039

    granted
  8. US 10278957

    Opioid agonist peptides and uses thereof

    Protagonist Therapeutics, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  9. US 10278374

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  10. US 10278976

    Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors

    MIRA DX, INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  11. US 10278994

    Method for the preparation of skipjack tuna extract having uric acid-lowering effect and the use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  12. US 10281475

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted
  13. US 10278982

    Method of treating heterotopic ossification

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 7, 2019 · Expires May 2, 2039

    granted
  14. US 10280423

    Compositions and methods for modulating complement factor B expression

    Ionis Pharmaceuticals, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  15. US 10280415

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted
  16. US 10280218

    Antibodies binding to BMP4, and uses thereof

    ACADEMISCH MEDISCH CENTRUM · Granted May 7, 2019 · Expires May 2, 2039

    granted
  17. US 10280197

    Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands

    The Regents of the University of California · Granted May 7, 2019 · Expires May 2, 2039

    granted
  18. US 10280175

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  19. US 10280171

    Heterocyclic inhibitors of PTPN11

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted
  20. US 10280307

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted
  21. US 10280229

    Linkers and their application towards ADC

    Medshine Discovery Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  22. US 10279176

    Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user

    FIRST STEP HOLDINGS, LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted
  23. US 10279040

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted
  24. US 10279039

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.